Cite
Cook DR, Kang M, Martin TD, et al. Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and Growth. Cancer Res. 2021;82(1):90-104doi: 10.1158/0008-5472.CAN-20-4218.
Cook, D. R., Kang, M., Martin, T. D., Galanko, J. A., Loeza, G. H., Trembath, D. G., Justilien, V., Pickering, K. A., Vincent, D. F., Jarosch, A., Jurmeister, P., Waters, A. M., Hibshman, P. S., Campbell, A. D., Ford, C. A., Keku, T. O., Yeh, J. J., Lee, M. S., Cox, A. D., Fields, A. P., Sandler, R. S., Sansom, O. J., Sers, C., Schaefer, A., & Der, C. J. (2022). Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and Growth. Cancer research, 82(1), 90-104. https://doi.org/10.1158/0008-5472.CAN-20-4218
Cook, Danielle R, et al. "Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and Growth." Cancer research vol. 82,1 (2022): 90-104. doi: https://doi.org/10.1158/0008-5472.CAN-20-4218
Cook DR, Kang M, Martin TD, Galanko JA, Loeza GH, Trembath DG, Justilien V, Pickering KA, Vincent DF, Jarosch A, Jurmeister P, Waters AM, Hibshman PS, Campbell AD, Ford CA, Keku TO, Yeh JJ, Lee MS, Cox AD, Fields AP, Sandler RS, Sansom OJ, Sers C, Schaefer A, Der CJ. Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and Growth. Cancer Res. 2022 Jan 01;82(1):90-104. doi: 10.1158/0008-5472.CAN-20-4218. Epub 2021 Nov 04. PMID: 34737214.
Copy
Download .nbib